deltatrials
Completed PHASE1 INTERVENTIONAL 8-arm NCT04336098

Study of SRF617 in Patients With Advanced Solid Tumors

A Phase 1 Study of SRF617 in Patients With Advanced Solid Tumors

Sponsor: Coherus Oncology, Inc.

Conditions Advanced Solid Tumor
Interventions Albumin-Bound Paclitaxel Gemcitabine Pembrolizumab SRF617
Updated 16 times since 2020 Last updated: Jun 3, 2024 Started: Mar 16, 2020 Primary completion: Aug 25, 2023 Completion: Aug 25, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Advanced Solid Tumor and is currently completed. Coherus Oncology, Inc. leads this study, which shows 16 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2020 – ~Aug 2020 · 3 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshot~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~Jun 2022 · 3 months · monthly snapshot~Jun 2022 – ~Dec 2022 · 6 months · monthly snapshot~Dec 2022 – ~Jul 2023 · 7 months · monthly snapshot~Jul 2023 – ~Sep 2023 · 2 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – present · 9 months · monthly snapshot

Change History

16 versions recorded

  1. Oct 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2025 — Oct 2025 [monthly]

    Completed PHASE1

  3. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  5. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

▶ Show 11 earlier versions

  1. Jul 2023 — Sep 2023 [monthly]

    Active Not Recruiting PHASE1

  2. Dec 2022 — Jul 2023 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  3. Jun 2022 — Dec 2022 [monthly]

    Recruiting PHASE1

  4. Mar 2022 — Jun 2022 [monthly]

    Recruiting PHASE1

  5. Jan 2022 — Mar 2022 [monthly]

    Recruiting PHASE1

  6. Sep 2021 — Jan 2022 [monthly]

    Recruiting PHASE1

  7. Mar 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

  8. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE1

  9. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  10. Aug 2020 — Nov 2020 [monthly]

    Recruiting PHASE1

  11. May 2020 — Aug 2020 [monthly]

    Recruiting PHASE1

    First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Coherus Oncology, Inc.
  • Merck Sharp & Dohme LLC
  • Surface Oncology
Data source: Coherus Oncology, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations